Stopped: Principal Investigator changing locations.
This is a single-center prospective pilot study of PureWick used as a management for nocturia and reduction of nighttime falls associated with going to the bathroom. Subjects are followed up to 3 months after the intervention. As a pilot study, it is expected that a 3-month follow-up will adequately capture urinary and sleep outcomes data and any adverse events related or unrelated to the study device.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
The proportion of patients at 3 months who have a demonstrated 50% or greater reduction in the number of nocturia episodes/night
Timeframe: 3 months
Change in average number of nocturnal voids at baseline and at 3 months
Timeframe: At baseline and 3 months
Change of scores on the N-QoL at baseline and at 3-months
Timeframe: At baseline and 3 months